Morgan Stanley Cuts IBM Price Target Amid Shift in Growth Expectations

Morgan Stanley has adjusted its investment stance on IBM, lowering the stock’s price target to $170 per share, down from $195, citing a more conservative view of the company’s revenue growth and margin expansion in the next 12 to 18 months. The firm noted that while IBM continues to make progress in its hybrid cloud and AI initiatives, execution risks and competitive pressures have tempered expectations for accelerated earnings growth. The revision comes amid broader scrutiny of IBM’s ability to scale its newer technology segments, particularly as it competes with larger cloud providers like Amazon Web Services and Microsoft Azure. Despite IBM’s recent gains in AI-driven enterprise software and its acquisition of Red Hat, Morgan Stanley emphasized that the integration timeline and return on investment remain uncertain, leading to a downward revision in projected operating margins. The updated price target implies a potential 14% downside from IBM’s current trading level, which stood at approximately $192 per share as of March 9, 2026. The firm maintained its ‘Equal Weight’ rating, signaling a neutral stance rather than a sell recommendation. This adjustment could influence institutional investors and fund managers reviewing their technology exposure, especially those with concentrated positions in legacy IT firms. Market reactions were limited, with IBM’s stock showing a modest 1.2% decline following the announcement. However, the move may prompt further analysis of IBM’s capital allocation strategy and its ability to generate consistent free cash flow in a high-interest-rate environment. The adjustment also underscores a broader trend among Wall Street analysts to temper enthusiasm for large-cap tech stocks that have seen rapid valuation increases in recent quarters.